Skip to main content
NAGE logo

NAGE · Niagen Bioscience, Inc. · Proposed Sales

Track NAGE — free
$2.50 +0.06 (+2.46%) At close · Oct 27 Q2 2026 earnings call transcript
Market Cap
$193.07M
Shares
79.13M
Volume · Oct 27 473.48K Avg daily vol (3M) 546.87K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2024-12-13 Frank Jaksch Jr. 37,161
2024-08-23 Kristin Patrick 23,000
Showing 1–2 of 2 filings
Key facts CIK 1386570 CUSIP 171077407 13F (30d) 17 filings 16 filers Visit website Investor relations